1. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE). (15th November 2016) Authors: Mrowietz, U.; Szepietowski, J.C.; Loewe, R.; van de Kerkhof, P.; Lamarca, R.; Ocker, W.G.; Tebbs, V.M.; Pau‐Charles, I. Journal: British journal of dermatology Issue: Volume 176:Number 3(2017) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE). (1st March 2017) Authors: Mrowietz, U.; Szepietowski, J.C.; Loewe, R.; van de Kerkhof, P.; Lamarca, R.; Ocker, W.G.; Tebbs, V.M.; Pau‐Charles, I. Journal: British journal of dermatology Issue: Volume 176:Number 3(2017) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗